Preview

Surgery and Oncology

Advanced search

Combination therapy for patients with advanced forms of distal rectal cancer during neoadjuvant thermoradiotherapy

https://doi.org/10.17650/2686-9594-2020-10-3-4-43-53

Abstract

Objective: to evaluate the efficacy of combination therapy in patients with stage сT3N0M0 and сT2–3N1–2M0 distal rectal cancer during a short course of neoadjuvant thermoradiotherapy compared to radiotherapy or surgical treatment alone.

Materials and methods. A total of 166 patients received 3 sessions of local microwave hyperthermia (LMH) at a temperature of 43–45 °C for 60 minutes during a short course of radiotherapy (LMH + CT); 138 patients received combination treatment (CT) using preoperative radiotherapy alone; 197 patients received surgical treatment (ST) only.

Results. In patients receiving LMH + CT, overall incidence of complications was 38.6 % and did not significantly differ from that in patients receiving ST (p = 0.8464) and CT (p = 0.5383). We observed no significant differences in the severity of postoperative complications (according to the Clavien–Dindo classification) between the three groups of study participants treated using different regimens. The incidence of relapses was 6 % in the LMH + CT group vs 17.3 % in the ST group (p <0.0011) and 10.9 % in the CT group (p = 0.1258). Relapse-free survival rates were significantly higher in patients receiving LMH + CT than in patients who had ST alone: 59.4 % vs 51 % (p = 0.04). Difference in relapse-free survival between the CT and ST groups was not significant (56.5 % vs 51 %, respectively, p = 0.07). The frequency of therapeutic pathomorphosis was significantly higher (p <0.00001) in the LMH + CT group than in the CT group (14.9 % and 1.5 %, respectively).

Conclusions. LMH has a universal radiosensitizing potential that can increase tumor radiosensitivity and improve treatment outcomes.

About the Authors

Yu. A. Barsukov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


S. I. Tkachev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


Z. Z. Mamedli
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


A. G. Perevoshchikov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


O. A. Vlasov
Russian Scientific Center of Radiology and Nuclear Medicine at the Ministry of Health of Russia
Russian Federation
86 Profsoyuznaya St., Moscow 117997


V. M. Kulushev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


V. A. Aliev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


S. V. Goncharov
Russian Scientific Center of Radiology and Nuclear Medicine at the Ministry of Health of Russia
Russian Federation
86 Profsoyuznaya St., Moscow 117997


References

1. Boyko A.V., Daryalova S.L., Demidova L.V. et al. Radiomodification in radiotherapy for malignant tumors (guidelines). Moscow, 1996. 11 p. (In Russ.).

2. Barsukov Yu.A. Combination treatment for rectal cancer. In: Cancer of the rectum and anal canal: outlooks of combination treatment. Moscow, 2019. Pp. 146–262. (In Russ.).

3. Garcia-Aguilar J., Marcet J., Coutsoftides T. et al. Impact of neoadjuvant chemotherapy following chemoradiation on tumor response, adverse events, and surgical complications in patients with advanced rectal cancer treated with TME. J Clin Oncol 2011;29(15 Suppl):3514.

4. NCCN Guidelines Insights: Rectal Cancer, Version 6. 2020. J Natl Compr Canc Netw 2020;18(7):806–15.

5. Glynne-Jones R., Wyrwicz L., Tiret E.G. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28(Suppl 4):iv22–40. DOI: 10.1093/annonc/mdx224.

6. Daryalova S.L., Boyko A.V., Chernichenko A.V. Current capabilities of radiation therapy for malignant tumors. Rossiiskii Onkologicheskii Zhurnal = Russian Journal of Oncology 2000;(1):48–55. (In Russ.).

7. Barsukov Yu.A., Tkachev S.I., Nikolaev A.V. et al. Preoperative thermoradiotherapy in combination treatment for lower rectal cancer. Voprosy onkologii = Problems in Oncology 1999;45(6):665–9. (In Russ.).

8. Tamrazov R.I., Barsukov Yu.A., Tkachev S.I. et al. Capabilities and outlooks of local hyperthermia in the combination treatment of rectal. Onkologicheskaya koloproktologiya = Colorectal Oncology 2011;3:12–21. (In Russ.).

9. Ballyuzek F.V., Ballyuzek M.F., Vilenskiy V.I. et al. Controlled hyperthermia. Saint Petersburg: Nevskiy Dialekt, 2001. 123 p. (In Russ.).

10. Dindo D., Demartines N., Clavien P.A. Classification of Surgical Complications. Ann Surg 2004;244:931–7.

11. Kholodin S.A. Tumors of the rectum and sigmoid colon. Moscow, 1977. 504 p. (In Russ.).

12. Glimelius B., Tiret E., Cervantes A. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Supp l6):vi81–8. DOI: 10.1093/annonc/mdt240.

13. NICE Clinical Guideline. Colorectal cancer: diagnosis and management. 2011. Available at: https://www.nice.org.uk/guidance/cg131.

14. Van der Valk M. ESS0 39-0251 Compliance acutе toxicity and postoperative complication of short-course radiothe rapia followed chemotherapy and sursery for high-risk rectal cancer. 39 th Congress of the European Society of Surgical Oncology.

15. LARC, abstr. 4006. Available at: https://meetinglibrary.asco.org/record/185464/abstract.


Review

Views: 566


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2949-5857 (Online)